Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8CR9

Cryo-EM structure of PcrV/Fab(30-B8)

Summary for 8CR9
Entry DOI10.2210/pdb8cr9/pdb
EMDB information16805
DescriptorHeavy chain, light chain, Maltose/maltodextrin-binding periplasmic protein,Type III secretion protein PcrV (3 entities in total)
Functional Keywordsantibody t3ss tip protein, antimicrobial protein
Biological sourceHomo sapiens
More
Total number of polymer chains3
Total formula weight122930.79
Authors
Yuan, B.,Simonis, A.,Marlovits, T.C. (deposition date: 2023-03-08, release date: 2023-11-22)
Primary citationSimonis, A.,Kreer, C.,Albus, A.,Rox, K.,Yuan, B.,Holzmann, D.,Wilms, J.A.,Zuber, S.,Kottege, L.,Winter, S.,Meyer, M.,Schmitt, K.,Gruell, H.,Theobald, S.J.,Hellmann, A.M.,Meyer, C.,Ercanoglu, M.S.,Cramer, N.,Munder, A.,Hallek, M.,Fatkenheuer, G.,Koch, M.,Seifert, H.,Rietschel, E.,Marlovits, T.C.,van Koningsbruggen-Rietschel, S.,Klein, F.,Rybniker, J.
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa.
Cell, 186:5098-5113.e19, 2023
Cited by
PubMed Abstract: Drug-resistant Pseudomonas aeruginosa (PA) poses an emerging threat to human health with urgent need for alternative therapeutic approaches. Here, we deciphered the B cell and antibody response to the virulence-associated type III secretion system (T3SS) in a cohort of patients chronically infected with PA. Single-cell analytics revealed a diverse B cell receptor repertoire directed against the T3SS needle-tip protein PcrV, enabling the production of monoclonal antibodies (mAbs) abrogating T3SS-mediated cytotoxicity. Mechanistic studies involving cryoelectron microscopy identified a surface-exposed C-terminal PcrV epitope as the target of highly neutralizing mAbs with broad activity against drug-resistant PA isolates. These anti-PcrV mAbs were as effective as treatment with conventional antibiotics in vivo. Our study reveals that chronically infected patients represent a source of neutralizing antibodies, which can be exploited as therapeutics against PA.
PubMed: 37918395
DOI: 10.1016/j.cell.2023.10.002
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (4.2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon